BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 102 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $944 | -15.3% | 328,900 | +49.0% | 0.00% | 0.0% |
| Q2 2023 | $1,115 | +171.3% | 220,700 | +1.5% | 0.00% | +100.0% |
| Q1 2023 | $411 | +3.5% | 217,500 | -1.4% | 0.00% | 0.0% |
| Q4 2022 | $397 | -99.9% | 220,613 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $368,000 | -45.0% | 217,700 | -20.0% | 0.00% | 0.0% |
| Q2 2022 | $669,000 | -8.7% | 272,002 | +2.8% | 0.00% | 0.0% |
| Q1 2022 | $733,000 | -64.3% | 264,491 | -31.4% | 0.00% | -66.7% |
| Q4 2021 | $2,054,000 | +355.4% | 385,400 | +1972.0% | 0.00% | +200.0% |
| Q1 2021 | $451,000 | -59.7% | 18,600 | -29.8% | 0.00% | 0.0% |
| Q2 2020 | $1,118,000 | – | 26,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $5,830,000 | 0.29% |
| K2 PRINCIPAL FUND, L.P. | 1,031,511 | $1,743,000 | 0.20% |
| Boxer Capital, LLC | 2,014,858 | $3,405,000 | 0.19% |
| DAFNA Capital Management LLC | 313,600 | $530,000 | 0.14% |
| Newtyn Management, LLC | 350,000 | $592,000 | 0.13% |
| Artal Group S.A. | 1,646,517 | $2,783,000 | 0.12% |
| Bellevue Group AG | 4,717,113 | $7,972,000 | 0.11% |
| MPM BioImpact LLC | 239,888 | $405,000 | 0.10% |
| RA Capital Management | 2,589,904 | $4,377,000 | 0.09% |
| Beacon Capital Management, LLC | 35,615 | $88,000 | 0.03% |